“Efficacy and Safety of Regorafenib Versus Dinutuximab With Chemotherapy in Chinese Children With Neuroblastoma”. 2019. Bangladesh Journal of Pharmacology 14 (1): 32-35. https://doi.org/10.3329/bjp.v14i1.38807.